Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Body weight lowering effect of glucose-dependent insulinotropic polypeptide and glucagon-like peptide receptor agonists is more efficient in RAMP1/3 KO than in WT mice

Autor: Leuthardt, Andrea S., Boyle, Christina N., Raun, Kirsten, Lutz, Thomas A., John, Linu M., Le Foll, Christelle

Publikováno v: In European Journal of Pharmacology 15 September 2023 955

Impact of glucagon-like peptide receptor agonists on endoscopy and its preoperative management: Guidelines, challenges, and future directions.

Autor: Singh S; Department of Internal Medicine, Sinai Hospital, Baltimore, MD 21215, United States., Suresh Kumar VC; Division of Gastroenterology and Hepatology, State University of New York Upstate Medical University, Syracuse, NY 13210, United States. drvishnucharan@gmail.com., Aswath G; Division of Gastroenterology and Hepatology, State University of New York Upstate Medical University, Syracuse, NY 13210, United States.

Publikováno v: World journal of gastrointestinal endoscopy [World J Gastrointest Endosc] 2024 Jun 16; Vol. 16 (6), pp. 292-296.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction: Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells.

Autor: Chang JT; Division of Nephrology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.; Department & Institute of Pharmacology, National Yang Ming University, Taipei, Taiwan., Liang YJ; Department and Institute of Life Science, Fu-Jen Catholic University, New Taipei, Taiwan.; Graduate Institute of Institute of Applied Science and Engineering, Fu-Jen Catholic University, New Taipei, Taiwan., Hsu CY; Department and Institute of Life Science, Fu-Jen Catholic University, New Taipei, Taiwan., Chen CY; Graduate Institute of Institute of Applied Science and Engineering, Fu-Jen Catholic University, New Taipei, Taiwan., Chen PJ; Graduate Institute of Institute of Applied Science and Engineering, Fu-Jen Catholic University, New Taipei, Taiwan., Yang YF; Graduate Institute of Institute of Applied Science and Engineering, Fu-Jen Catholic University, New Taipei, Taiwan., Chen YL; Department of Pathology, Cardinal Tien Hospital, Medical School, Fu Jen Catholic University, New Taipei City, Taiwan.; Fu-Jen Catholic University School of Medicine, No. 510, Zhongzheng Road, Xinzhuang District, 24205, New Taipei City, Taiwan., Pei D; Division of Endocrinology and Metabolism, Department of Internal Medicine, Cardinal Tien Hospital, Medical School, Fu Jen Catholic University, New Taipei City, Taiwan.; Fu-Jen Catholic University School of Medicine, No. 510, Zhongzheng Road, Xinzhuang District, 24205, New Taipei City, Taiwan., Chang JB; Department of Pathology, Division of Clinical Pathology, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan., Leu JG; Division of Nephrology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. 056111@mail.fju.edu.tw.; Fu-Jen Catholic University School of Medicine, No. 510, Zhongzheng Road, Xinzhuang District, 24205, New Taipei City, Taiwan. 056111@mail.fju.edu.tw.

Publikováno v: BMC pharmacology & toxicology [BMC Pharmacol Toxicol] 2023 Oct 27; Vol. 24 (1), pp. 57. Date of Electronic Publication: 2023 Oct 27.